RI Intranet Portal
Message from the Interim Executive Director
The RI-MUHC in Numbers
Our Vision and Mission
RI-MUHC Board of Directors
Research across Our Sites
News and Events
Study at the RI-MUHC
The Desjardins Centre for Advanced Training
Reasons to work at the RI-MUHC
Cancer Research Program
Brain Repair and Integrative Neuroscience Program
Cancer Research Program
Leadership and Management
Cardiovascular Health Across the Lifespan Program
Child Health and Human Development Program
Metabolic Disorders and Complications Program
Infectious Diseases and Immunity in Global Health Program
Injury Repair Recovery Program
Translational Research in Respiratory Diseases Program
Unprecedented Canada-wide movement to improve pediatric cancer treatment
In Canada, cancer remains the leading cause of illness-related death in children. In an effort to accelerate research breakthroughs...
Research trainees, enter the CFI’s #IAmInnovation Twitter contest to win!
Calling all students and post-docs — between October 2 and December 1, 2017, the Canada Foundation for Innovation (CFI) wants to hear how working in state-of-the-art facilities and with cutting-edge equipment has helped you and...
Searching for the “signature” causes of BRCAness in breast cancer
Breast cancer cells with defects in the DNA damage repair–genes BRCA1 and BRCA2 have a mutational signature...
Joint Summer Student Research Day: A new part of the summer culture
For students eager to spend a few months in a leading research laboratory and conduct a hands-on project, summer is the time to try it...
Encouraging results for patients with aggressive brain cancer
Being diagnosed with a malignant brain tumor is devastating news for patients and their loved ones. Whereas some types...
Dr. Patricia Tonin receives the Karen Campbell Award for Research Excellence
Dr. Patricia Tonin, professor of the McGill University departments of Medicine and Human Genetics and associate leader of the Cancer Research Program of the Research Institute...
Dr. Morag Park awarded prestigious Robert L. Noble Prize
Dr. Morag Park, Professor of Biochemistry, Medicine and Oncology and Director of the Goodman Cancer Research Centre at McGill...
New marker and potential therapy for triple negative breast cancer
Triple negative breast cancer (TNBC) is the most aggressive type of breast cancer, found in 15-20% of all cases. These breast tumors are...
New marker identified for pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is the fourth leading cause of cancer-related deaths. Due to its deep anatomical location, tumour-specific symptoms typically occur only...
A race against time to diagnose deadly weight loss in cancer patients
About one third of cancer patients die because of cachexia – an involuntary weight loss, characterized primarily by muscle wasting and metabolic changes, which cannot be addressed or treated solely...